A pilot trial of In vivo NRT sampling to increase medication adherence in community corrections smokers

Addictive Behaviors

Volumn 67, Issue , 2017, Pages 92-99

  Cropsey, Karen L ^a   Hendricks, Peter S ^b   Schiavon, Samantha ^a   Sellers, Aaron ^a   Froelich, Morgan ^a   Shelton, Richard C ^a   Carpenter, Matthew J ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Craving; Medication adherence; Nicotine replacement therapy; Withdrawal

Indexed keywords

CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; CRAVING; CRIMINAL JUSTICE; DISEASE MODEL; DRUG WITHDRAWAL; HUMAN; MEDICATION COMPLIANCE; NICOTINE REPLACEMENT THERAPY; NORMAL HUMAN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLING; SMOKING CESSATION; BEHAVIOR THERAPY; FEMALE; MALE; PRISONER; PROCEDURES; SMOKING; STATISTICS AND NUMERICAL DATA;

NICOTINE GUM;

BEHAVIOR THERAPY; CRAVING; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PILOT PROJECTS; PRISONERS; SMOKERS; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

EID: 85008199304     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2016.12.011     Document Type: Article

References (56)

1. Appollonio, D., Philipps, R., Bero, L., Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database of Systematic Reviews 11 (2016), 1–55, 10.1002/14651858.CD010274.pub2.
2. Baldwin, A.S., Rothman, A.J., Hertel, A.W., Linde, J.A., Jeffery, R.W., Finch, E.A., Lando, H.A., Specifying the determinants of the intuition and maintenance of behavior change: An examination of self-efficacy, satisfaction, and smoking cessation. Health Psychology 25 (2006), 626–634.
3. Balmford, J., Borland, R., Hammond, D., Cummings, K.M., Adherence to and reasons for premature discontinuation from stop-smoking medications: Data from the ITC Four-Country Survey. Nicotine & Tobacco Research 13 (2011), 94–102, 10.1093/ntr/ntq215.
4. Boardman, T., Catley, D., Mayo, M.S., Ahluwalia, J.S., Self-efficacy and motivation to quit during participation in a smoking cessation program. Journal of Behavioral Medicine 12 (2005), 266–272, 10.1207/s15327558ijbm1204_7.
5. Cahill, K., Stevens, S., Perera, R., Lancaster, T., Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database of Systematic Reviews(5), 2013, CD009329, 10.1002/14651858.CD009329.pub2.
6. Carpenter, M.J., Ford, M.E., Cartmell, M.D.K., Alberg, A.J., Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. Journal of the National Medical Association, 103, 2011, 885.
7. Carpenter, M.J., Hughes, J.R., Gray, K.M., Wahlquist, A.E., Saladin, M.E., Alberg, A.J., Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: A randomized clinical trial. JAMA Internal Medicine 171 (2011), 1901–1907, 10.1001/archinternmed.2011.492.
8. Carson, E.A., Sabol, W.J., Prisoners in 2011. December, 2012, U.S. Department of Justice, Bureau of Justice Statistics (NCJ 239808).
9. Centers for Disease Control and Prevention, Quitting smoking among adults–United States, 2001–2010. MMWR. Morbidity and Mortality Weekly Report, 60, 2011, 1513 https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a2.htm (accessed 2014 June 13).
10. Centers for Disease Control and Prevention, Current cigarette smoking among adults—United States, 2005–2012. Morbidity and Mortality Weekly Report 63 (2014), 29–34 http://www.cdc.gov/MMWR/preview/mmwrhtml/mm6302a2.htm (accessed 2014 Feb 14).
11. Cooney, N.L., Cooney, J.L., Perry, B.L., Carbone, M., Cohen, E.H., Steinberg, H.R.,.. Litt, M.D., Smoking cessation during alcohol treatment: A randomized trial of combination nicotine patch plus nicotine gum. Addiction 104 (2009), 1588–1596.
12. Cox, L.S., Tiffany, S.T., Christen, A.G., Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research 3 (2001), 7–16.
13. Covey, L.S., Botello-Harbaum, M., Glassman, A.H., Masmela, J., LoDuca, C., Salzman, V., Fried, J., Smokers’ response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. Ethnicity & Disease 18 (2007), 59–64.
14. Cropsey, K.L., Clark, C.B., Hendricks, P.S., Varenicline for smoking reduction prior to cessation. JAMA 313 (2015), 2284–2285, 10.1001/jama/.2015.4972.
15. Cropsey, K.L., Clark, C.B., Zhang, X., Hendricks, P.S., Jardin, B.F., Lahti, A.C., Race and medication adherence moderate cessation outcomes in criminal justice smokers. JAMA 49 (2015), 335–344, 10.1016/j.amepre.2015.03.014.
16. Cropsey, K.L., Eldridge, G.D., Weaver, M.F., Villalobos, G.C., Stitzer, M.L., Best, A.M., Smoking cessation intervention for female prisoners: Addressing an urgent public health need. American Journal of Public Health 98 (2008), 1894–1901, 10.2105/AJPH.2007.128207.
17. Cropsey, K.L., Jones-Whaley, S., Jackson, D.O., Hale, G.J., Smoking characteristics of community corrections clients. Nicotine & Tobacco Research 12 (2010), 53–58.
18. Cropsey, K.L., Trent, L.R., Clark, C.B., Stevens, E.N., Lahti, A.C., Hendricks, P.S., How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine & Tobacco Research 16 (2014), 1348–1355, 10.1093/ntr/ntu085.
19. Cutler, D.M., Everett, W., Thinking outside the pillbox—Medication adherence as a priority for health care reform. New England Journal of Medicine 362 (2010), 1553–1555, 10.1056/NEJMp1002305.
20. DeFulio, A., Silverman, K., The use of incentives to reinforce medication adherence. Preventive Medicine 55 (2012), S86–S94, 10.1016/j.ypmed.2012.04.017.
21. Demonceau, J., Ruppar, T., Kristanto, P., Hughes, D.A., Fargher, E., Kardas, P.,.. Vrijens, B., Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs 73 (2013), 545–562, 10.1007/s40265-013-0041-3.
22. Etter, J.F., Perneger, T.V., Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clinical Pharmacology and Therapeutics 69 (2001), 175–183.
23. Fant, R.V., Henningfield, J.E., Shiffman, S., Strahs, K.R., Reitberg, D.P., A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharmacology, Biochemistry, and Behavior 67 (2000), 479–482.
24. Ferguson, S.G., Shiffman, S., Gitchell, J.G., Nicotine replacement therapies: Patient safety and persistence. Patient Related Outcome Measures 2 (2011), 111–117, 10.2147/PROM.S11545.
25. Ferguson, S.G., Gitchell, J.G., Shiffman, S., Sembower, M.A., Rohay, J.M., Allen, J., Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addictive Behaviors 36 (2011), 713–716, 10.1016/j.addbeh.2011.02.002.
26. Fiore, M.C., Bailey, W.C., Cohen, S.J., Dorfman, S.F., Goldstein, M.G., Gritz, E.R.,.. Mecklenburg, R.E., Treating tobacco use and dependence: Clinical practice guideline. 2000, US Department of Health and Human Services, Rockville, MD, 00–0032.
27. Halpern, V., Lopez, L.M., Grimes, D.A., Stockton, L.L., Gallo, M.F., Strategies to improve adherence and acceptability of hormonal methods of contraception. (Cochrane Library), 2013, 10.1002/14651858.CD004317.
28. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerström, K.O., The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 86 (1991), 1119–1127.
29. Hedeker, D., Mermelstein, R.J., Demirtas, H., Analysis of binary outcomes with missing data: Missing = smoking, last observation carried forward, and a little multiple imputation. Addiction 102 (2007), 1564–1573.
30. Hughes, J.R., Hatsukami, D., Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43 (1986), 289–294.
31. Jardin, B.F., Cropsey, K.L., Wahlquist, A.E., Gray, K.M., Silvestri, G.A., Cummings, K.M., Carpenter, M.J., Evaluating the effect of access to free medication to quit smoking: A clinical trial testing the role of motivation. Nicotine & Tobacco Research, 2014 ntu025 10.1093/ntr/ntu025.
32. Juliano, L.M., Brandon, T.H., Smokers’ expectancies for nicotine replacement therapy vs. cigarettes. Nicotine & Tobacco Research 6 (2004), 569–574.
33. Kiortsis, D.N., Giral, P., Bruckert, E., Turpin, G., Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. Journal of Clinical Pharmacy and Therapeutics 25 (2000), 445–451.
34. McDonald, H.P., Garg, A.X., Haynes, R.B., Interventions to enhance patient adherence to medication prescriptions: Scientific review. JAMA 288 (2002), 2868–2879.
35. Mendelsohn, C., Optimising nicotine replacement therapy in clinical practice. Australian Family Physician 42 (2013), 305–309.
36. Mooney, M.E., Leventhal, A.M., Hatsukami, D.K., Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine & Tobacco Research 8 (2006), 435–446.
37. Pieh-Holder, K.L., Callahan, C., Young, P., Qualitative needs assessment: Healthcare experiences of underserved populations in Montgomery County, Virginia, USA. Rural and Remote Health, 12, 2012, 1816.
38. Perkins, K.A., Karelitz, J.L., Jao, N.C., Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine & Tobacco Research 15 (2013), 978–982, 10.1093/ntr/nts205.
39. Raupach, T., Brown, J., Herbec, A., Brose, L., West, R., A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction 109 (2014), 35–43, 10.1111/add.12319.
40. Roebuck, M.C., Liberman, J.N., Gemmill-Toyama, M., Brennan, T., Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs 30 (2011), 91–99, 10.1377/hlthaff.2009.1087.
41. Ryan, K.K., Garrett-Mayer, E., Alberg, A.J., Cartmell, K.B., Carpenter, M.J., Predictors of cessation pharmacotherapy use among Black and non-Hispanic White smokers. Nicotine & Tobacco Research 13 (2011), 646–652, 10.1093/ntr/ntr051.
42. Schneider, N.G., Koury, M.A., Cortner, C., Olmstead, R.E., Hartman, N., Kleinman, L.,.. Leaf, D., Preferences among four combination nicotine treatments. Psychopharmacology 187 (2006), 476–485.
43. Schneider, N.G., Cortner, C., Justice, M., Gould, J.L., Amor, C., Hartman, N.,.. Olmstead, R.E., Preferences among five nicotine treatments based on information versus sampling. Nicotine & Tobacco Research 10 (2008), 179–186, 10.1080/14622200701767837.
44. Sewell, K., Andreae, S., Luke, E., Safford, M.M., Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011. Preventing Chronic Disease, 9, 2012, E142, 10.5888/pcd9.120010.
45. Shiffman, S., Sweeney, C.T., Ferguson, S.G., Sembower, M.A., Gitchell, J.G., Relationship between adherence to daily nicotine patch use and treatment efficacy: Secondary analysis of a 10 week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clinical Therapeutics 30 (2008), 1852–1858, 10.1016/j.clinthera.2008.09.016.
46. Shiffman, S., Ferguson, S.G., Rohay, J., Gitchell, J.G., Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance. Addiction 103 (2008), 1371–1378, 10.1111/j.1360-0443.2008.02268.x.
47. Shiffman, S., Shadel, W.G., Niaura, R., Khayrallah, M.A., Jorenby, D.E., Ryan, C.F., Ferguson, C.L., Efficacy of acute administration of nicotine gum in relief of cue provoked cigarette craving. Psychopharmacology 166 (2003), 343–350.
48. Simeonova, E., Doctors, patients and the racial mortality gap. Journal of Health Economics 32 (2013), 895–908, 10.1016/j.jhealeco.2013.07.002.
49. Smith, S.S., Piper, M.E., Bolt, D.M., Fiore, M.C., Wetter, D.W., Cinciripini, P.M., Baker, T.B., Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine & Tobacco Research 12 (2010), 489–499, 10.1093/ntr/ntq032.
50. Stead, L.F., Perera, R., Bullen, C., Mant, D., Lancaster, T., Nicotine replacement therapy for smoking cessation. 2008 (The Cochrane Library).
51. Tran, K., Asakawa, K., Cimon, K., Moulton, K., Kaunelis, D., Pipe, A., Selby, P., Pharmacologic-based strategies for smoking cessation: Clinical and cost-effectiveness analyses. 2010, Canadian Agency for Drugs and Technologies in Health, Ottawa (Technology Report; no. 130). Available from http://www.cadth.ca/media/pdf/H0486_Smoking_Cessation_tr_e.pdf.
52. U.S. Department of Health and Human Services, Tobacco use among U.S. Racial/Ethnic Minority Groups—African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A report of the surgeon general. 1998, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, Georgia http://www.cdc.gov/mmwr/preview/mmwrhtml/00055081.htm.
53. Van Camp, Y.P., Van Rompaey, B., Elseviers, M.M., Nurse-led interventions to enhance adherence to chronic medication: Systematic review and meta-analysis of randomised controlled trials. European Journal of Clinical Pharmacology 69 (2013), 761–770, 10.1007/s00228-012-1419-y.
54. Viswanathan, M., Golin, C.E., Jones, C.D., Ashok, M., Blalock, S.J., Wines, R.C.,.. Lohr, K.N., Interventions to improve adherence to self-administered medications for chronic diseases in the United States: A systematic review. Annals of Internal Medicine 157 (2012), 785–795.
55. Viswanathan, M., Golin, C.E., Jones, C.D., Ashok, M., Blalock, S., Wines, R.C.,.. Sista, P., Closing the quality gap: Revisiting the state of the science. Medication adherence interventions: Comparative effectiveness, Vol. 4, 2012.
56. Windle, S.B., Filion, K.B., Mancini, J.G., Adye-White, L., Joseph, L., Gore, G.C.,.. Eisenberg, M.J., Combination therapies for smoking cessation: A hierarchical Bayesian meta-analysis. American Journal of Preventive Medicine 51 (2016), 1060–1071.